The first international workshop on gender dimorphism in cancer will take place next March, organised among others by the speakers of the oncology module of the CAS. The role of hormonal and genetic differences in cancer susceptibility and response to treatment is still poorly understood. To meet this challenge, there is an urgent need to foster interdisciplinary cross-communication efforts and train the next generation of researchers in basic and translational cancer prevention. Find out more at https://2021sdcmeeting.vfairs.com or on the workshop poster:
Under the title “Men – The Weak Covid Sex”, Swiss Television’s health programme “Puls” focused on Monday 21 September on the sex differences in Covid-19 courses. CAS programme director Catherine Gebhard explains the current theories and presents her research in the section: https://www.srf.ch/play/tv/redirect/detail/d020b6eb-d5ff-4bec-bd1c-cad9be5e2c75
The Federal Council must draw up a report on the possible discrimination of women in health care. On Thursday 18 June 2020 the National Council approved a postulate to this effect by Laurence Fehlmann Rielle (SP/GE) with 113 to 69 votes.
Fehlmann criticised that the suffering of women was often not taken seriously. Moreover, research projects and clinical trials were all too often conducted exclusively with men. This leads to recommendations that do not meet the needs of women and to the prescription of drugs that are unsuitable for certain women. In medicine, the man is still considered a prototype.
Even before the postulate was dealt with in the National Council, the Federal Council had already agreed to present a report on the extent to which women were disadvantaged in medical research, prevention and care. It is undeniable that there are inequalities between women and men in this area, said Federal Councillor Alain Berset. These are attributable to both biological and social factors. “What we lack in Switzerland is an overview of the results of relevant studies on the measures that have already been taken and the recommendations that could improve this situation.” Berset pointed out that only a small part of the possible measures are within the competence of the Confederation. Nevertheless, the planned report could serve as a basis for the elaboration of concrete measures with various actors.
Postulat Fehlmann: https://www.parlament.ch/de/ratsbetrieb/suche-curia-vista/geschaeft?AffairId=20193910 (German)
Given the current situation regarding the new coronavirus we have come to the conclusion that the implementation of the CAS is currently not possible within the desired framework. Since networking and personal exchange of experiences and opinions are an important part of the CAS, we also do not want to conduct the continuing education course online.
Therefore, we have decided to postpone the start of the CAS in Sex- and Gender-Specific Medicine until March 2021. The exact dates of the individual modules will be announced as soon as possible.
The CAS in Sex- and Gender-Specific Medicine is mentioned in an article about professor Vera Regitz-Zagrosek in the European Heart Journal:
“Another important project for Vera is her contribution to the certificate of advanced studies (CAS) for ‘Sex- and Gender-Specific Medicine’ of the universities of Bern and Zurich. This CAS initiated by Professor Daniel Candinas, Vice-Rector for Research of the Universityof Bern and Professor Beatrice Beck Schimmer will be open for post-graduate students from various fields. The program is coordinated by Professor Cathérine Gebhard, professor for cardiovascular gender-specific medicine and cardiac imaging at Zurich University and the University Hospital Zurich. The course modules include cardiovascular medicine, endocrinology and metabolism, sex- and gender-specific study design, neurology and psychiatry, pharmacology, public health,and other topics. The curriculum teaches a broad and comprehensive spectrum in gender-specific medicine. The start is envisioned for May 2020.”